Open Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Open clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 481 trials

Recruiting
Phase 2

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

Immune Thrombocytopenia
Incyte Corporation56 enrolled40 locationsNCT07104565
Recruiting
Phase 3

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

Immune Thrombocytopenia
Sanofi60 enrolled20 locationsNCT07007962
Recruiting
Phase 1

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Antiphospholipid Syndrome (APS)Immune-mediated Necrotizing Myopathy (IMNM)Immune Thrombocytopenia (ITP)+3 more
Chugai Pharmaceutical144 enrolled69 locationsNCT06371417
Recruiting
Phase 3

A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Immune Thrombocytopenic Purpura (ITP)
Takeda150 enrolled98 locationsNCT06948318
Recruiting
Phase 1

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT04097561
Recruiting
Phase 2

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Idiopathic CD4-PositiveT-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID)40 enrolled1 locationNCT02015013
Recruiting
Phase 2Phase 3

Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension

OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
Qlaris Bio, Inc.60 enrolled1 locationNCT07354516
Recruiting
Phase 1Phase 2

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NeutropeniaInfectionsWarts+2 more
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT00967785
Recruiting
Not Applicable

Association of TNFAIP3 With Immune-mediated TTP

Thrombotic Thrombocytopenic Purpura, Acquired
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico400 enrolled1 locationNCT06928233
Recruiting
Not Applicable

Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia

SarcopeniaType 2 Diabetes Mellitus (T2DM)
yueh chu wu128 enrolled1 locationNCT07398495
Recruiting
Not Applicable

Effect of Micronized Creatine Monohydrate on Muscle Mass, Strength and Performance in Older Adults Submitted to Total Knee Arthroplasty

Physical PerformanceFrailty at Older AdultsFunctional Capacity+3 more
Consorci Sanitari del Maresme262 enrolled1 locationNCT06925880
Recruiting
Not Applicable

Preserflo MicroShunt Versus Trabeculectomy

GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Medical University of Bialystok100 enrolled1 locationNCT07496957
Recruiting
Phase 1Phase 2

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

ITPImmune Thrombocytopenia (ITP)Monoclonal+2 more
Climb Bio, Inc.24 enrolled20 locationsNCT07043946
Recruiting
Not Applicable

A Trial of Hydrus Microstent Versus Goniotomy

GlaucomaGlaucoma, Open-Angle
Massachusetts Eye and Ear Infirmary243 enrolled1 locationNCT06289491
Recruiting
Phase 2

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

Myelodysplastic SyndromeMyelofibrosisPolycythemia Vera+2 more
University of Southern California30 enrolled2 locationsNCT06063486
Recruiting

Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery

SarcopeniaLung Cancer (Non-Small Cell)Malnutrition Severe
Ondokuz Mayıs University142 enrolled1 locationNCT07500376
Recruiting
Not Applicable

Neonatal Platelet Transfusion Threshold Trial

ThrombocytopeniaNeonatal
NICHD Neonatal Research Network2,433 enrolled20 locationsNCT06676904
Recruiting

Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia Patients

MDSCytopenia
Weizmann Institute of Science1,500 enrolled2 locationsNCT07081087
Recruiting
Not Applicable

HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke

SarcopeniaStroke, Ischemic
Fenerbahce University32 enrolled1 locationNCT07456956
Recruiting

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Cryptococcal MeningitisWartsIdiopathic CD4+ Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID)950 enrolled1 locationNCT00867269